Process for producing a particulate composition comprising anhydrous crystalline 2-O-alpha-D-glucosyl-L-ascorbic acid
US-9265781-B2 · Feb 23, 2016 · US
US9872872B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9872872-B2 |
| Application number | US-201514879280-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 9, 2015 |
| Priority date | Sep 3, 2009 |
| Publication date | Jan 23, 2018 |
| Grant date | Jan 23, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides a process for enabling the production of a particulate composition containing anhydrous crystalline ascorbic acid 2-glucoside that does not significantly cake even when the production yield of ascorbic acid 2-glucoside does not reach 35% by weight. The process for producing a particulate composition containing anhydrous crystalline ascorbic acid 2-glucoside, which comprises allowing a CGTase to act on a solution containing either liquefied starch or dextrin and L-ascorbic acid and then allowing a glucoamylase to act on the resulting solution to obtain a solution with an ascorbic acid 2-glucoside production yield of at least 27%, purifying the obtained solution to increase the ascorbic acid 2-glucoside content to a level of over 86% by weight, precipitating anhydrous crystalline ascorbic acid 2-glucoside by a controlled cooling method or pseudo-controlled cooling method, collecting the precipitated anhydrous crystalline ascorbic acid 2-glucoside, and ageing and drying the collected anhydrous crystalline ascorbic acid 2-glucoside.
Opening claim text (preview).
What is claimed is: 1. A particulate composition comprising anhydrous crystalline 2-O-α-D-glucosyl-L-ascorbic acid, which comprises 2-O-α-D-glucosyl-L-ascorbic acid in an amount of over 98.0% by weight but 99.8% by weight or lower, on a dry solid basis; which has a degree of crystallinity of 90% or higher for anhydrous crystalline 2-O-α-D-glucosyl-L-ascorbic acid, when calculated based on a profile of powder X-ray diffraction analysis of said composition; which contains particles with a particle size of less than 150 μm in an amount of 70% by weight or higher to the whole particulate composition, and those with a particle size of at least 53 μm but less than 150 μm in an amount of 40 to 60% by weight to the whole composition; and which has a reducing power of the whole composition being less than one percent by weight.
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Free radical scavengers or antioxidants · CPC title
produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins · CPC title
Heterocyclic radicals containing only oxygen as ring hetero atoms · CPC title
Cyclomaltodextrin glucanotransferase (2.4.1.19) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.